TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14877 · Jun 28

#python#bounty#bugbounty#bypass#cheatsheet#enumeration#hacking#hacktoberfest#methodology#payload#payloads#penetration_testing#pentest#privilege_escalation#redteam#security#vulnerability#web_application Payloads All The Things is a comprehensive collection of useful payloads and bypass techniques for web application security testing and penetration testing. It offers detailed documentation for each vulnerability, including how to exploit it and ready-to-use payloads, plus files for tools like Burp Intruder. You can contribute your own payloads or improvements, making it a collaborative resource. It also links to related projects for internal network and hardware pentesting, and provides learning resources like books and videos. Using this resource helps you efficiently find and test security weaknesses in web applications, improving your pentesting effectiveness and knowledge. https://github.com/swisskyrepo/PayloadsAllTheThings

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment